← Browse by Condition
Medical Condition

insomnia disorder

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 4, Phase 3

ClinicalMetric tracks all active clinical trials for insomnia disorder sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3
1
Phase 4
1
Top Sponsors
University Hospital, Montpellier 1 trial
Vanda Pharmaceuticals 1 trial

Recruiting Clinical Trials

NCT05924425 Phase 4
Recruiting

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

Enrollment
62 pts
Location
France
Sponsor
University Hospital, Montpelli...
View Trial →
NCT06953869 Phase 3
Recruiting

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

Enrollment
420 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology